Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 31 March 2023
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
59
Renminbi (CNY)
17
Euro (EUR)
11
Swiss franc (CHF)
5
Indian rupee (INR)
4
Other currencies (CAD, DKK, GBP, HDK, SEK)
4
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
35
Public (from private) companies
26
Public companies
17
Cash and cash equivalents
12
Funds
9
Other assets
1
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
42
Products on the market
26
Preclinical
7
Phase I
7
Phase II
13
Phase III
5
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
25
Synthetic biology
20
Oncology
16
Digital Health
11
Central nervous system
10
Immunology/Inflammation
6
Orphan diseases
6
Medical technology / diagnostics
6
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8